世界のリウマチ薬市場：市場規模・現状・予測

• 英文タイトル：Global Rheumatology Drugs Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7975
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、リウマチ薬のグローバル市場について調査・分析したレポートで、種類別（疾患修飾性抗リウマチ薬、非ステロイド性抗炎症薬、コルチコステロイド、尿酸薬、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・リウマチ薬の世界市場規模
・主要企業別市場シェア
・リウマチ薬の世界市場規模：種類別（疾患修飾性抗リウマチ薬、非ステロイド性抗炎症薬、コルチコステロイド、尿酸薬、その他）
・リウマチ薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局）
・リウマチ薬のアメリカ市場規模（種類別、用途別）
・リウマチ薬のヨーロッパ市場規模（種類別、用途別）
・リウマチ薬の中国市場規模（種類別、用途別）
・リウマチ薬の日本市場規模（種類別、用途別）
・リウマチ薬の東南アジア市場規模（種類別、用途別）
・リウマチ薬のインド市場規模（種類別、用途別）
・リウマチ薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・リウマチ薬の世界市場予測（2019年-2025年）
・リウマチ薬の地域別市場予測（2019年-2025年）
...

In 2018, the global Rheumatology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Rheumatology Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Rheumatology Drugs development in United States, Europe and China.

The key players covered in this study
Takeda Pharmaceutical
Sanofi
Genentech
Novartis
Janssen Biotech
Amgen
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck & Co.

Market segment by Type, the product can be split into
Disease Modifying Anti-rheumatic Drugs
Nonsteroidal Anti-inflammatory Drugs
Corticosteroids
Uric Acid Drugs
Others

Market segment by Application, split into
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Rheumatology Drugs status, future forecast, growth opportunity, key market and key players.
To present the Rheumatology Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Rheumatology Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Rheumatology Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Disease Modifying Anti-rheumatic Drugs
1.4.3 Nonsteroidal Anti-inflammatory Drugs
1.4.4 Corticosteroids
1.4.5 Uric Acid Drugs
1.4.6 Others
1.5 Market by Application
1.5.1 Global Rheumatology Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacy
1.5.3 Retail Pharmacy
1.5.4 Online Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Rheumatology Drugs Market Size
2.2 Rheumatology Drugs Growth Trends by Regions
2.2.1 Rheumatology Drugs Market Size by Regions (2014-2025)
2.2.2 Rheumatology Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Rheumatology Drugs Market Size by Manufacturers
3.1.1 Global Rheumatology Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Rheumatology Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Rheumatology Drugs Key Players Head office and Area Served
3.3 Key Players Rheumatology Drugs Product/Solution/Service
3.4 Date of Enter into Rheumatology Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Rheumatology Drugs Market Size by Type (2014-2019)
4.2 Global Rheumatology Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Rheumatology Drugs Market Size (2014-2019)
5.2 Rheumatology Drugs Key Players in United States
5.3 United States Rheumatology Drugs Market Size by Type
5.4 United States Rheumatology Drugs Market Size by Application

6 Europe
6.1 Europe Rheumatology Drugs Market Size (2014-2019)
6.2 Rheumatology Drugs Key Players in Europe
6.3 Europe Rheumatology Drugs Market Size by Type
6.4 Europe Rheumatology Drugs Market Size by Application

7 China
7.1 China Rheumatology Drugs Market Size (2014-2019)
7.2 Rheumatology Drugs Key Players in China
7.3 China Rheumatology Drugs Market Size by Type
7.4 China Rheumatology Drugs Market Size by Application

8 Japan
8.1 Japan Rheumatology Drugs Market Size (2014-2019)
8.2 Rheumatology Drugs Key Players in Japan
8.3 Japan Rheumatology Drugs Market Size by Type
8.4 Japan Rheumatology Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Rheumatology Drugs Market Size (2014-2019)
9.2 Rheumatology Drugs Key Players in Southeast Asia
9.3 Southeast Asia Rheumatology Drugs Market Size by Type
9.4 Southeast Asia Rheumatology Drugs Market Size by Application

10 India
10.1 India Rheumatology Drugs Market Size (2014-2019)
10.2 Rheumatology Drugs Key Players in India
10.3 India Rheumatology Drugs Market Size by Type
10.4 India Rheumatology Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Rheumatology Drugs Market Size (2014-2019)
11.2 Rheumatology Drugs Key Players in Central & South America
11.3 Central & South America Rheumatology Drugs Market Size by Type
11.4 Central & South America Rheumatology Drugs Market Size by Application

12 International Players Profiles
12.1 Takeda Pharmaceutical
12.1.1 Takeda Pharmaceutical Company Details
12.1.2 Company Description and Business Overview
12.1.3 Rheumatology Drugs Introduction
12.1.4 Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2014-2019)
12.1.5 Takeda Pharmaceutical Recent Development
12.2 Sanofi
12.2.1 Sanofi Company Details
12.2.2 Company Description and Business Overview
12.2.3 Rheumatology Drugs Introduction
12.2.4 Sanofi Revenue in Rheumatology Drugs Business (2014-2019)
12.2.5 Sanofi Recent Development
12.3 Genentech
12.3.1 Genentech Company Details
12.3.2 Company Description and Business Overview
12.3.3 Rheumatology Drugs Introduction
12.3.4 Genentech Revenue in Rheumatology Drugs Business (2014-2019)
12.3.5 Genentech Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Rheumatology Drugs Introduction
12.4.4 Novartis Revenue in Rheumatology Drugs Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Janssen Biotech
12.5.1 Janssen Biotech Company Details
12.5.2 Company Description and Business Overview
12.5.3 Rheumatology Drugs Introduction
12.5.4 Janssen Biotech Revenue in Rheumatology Drugs Business (2014-2019)
12.5.5 Janssen Biotech Recent Development
12.6 Amgen
12.6.1 Amgen Company Details
12.6.2 Company Description and Business Overview
12.6.3 Rheumatology Drugs Introduction
12.6.4 Amgen Revenue in Rheumatology Drugs Business (2014-2019)
12.6.5 Amgen Recent Development
12.7 AbbVie
12.7.1 AbbVie Company Details
12.7.2 Company Description and Business Overview
12.7.3 Rheumatology Drugs Introduction
12.7.4 AbbVie Revenue in Rheumatology Drugs Business (2014-2019)
12.7.5 AbbVie Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Rheumatology Drugs Introduction
12.8.4 Pfizer Revenue in Rheumatology Drugs Business (2014-2019)
12.8.5 Pfizer Recent Development
12.9 Bristol-Myers Squibb Company
12.9.1 Bristol-Myers Squibb Company Company Details
12.9.2 Company Description and Business Overview
12.9.3 Rheumatology Drugs Introduction
12.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2014-2019)
12.9.5 Bristol-Myers Squibb Company Recent Development
12.10 Merck & Co.
12.10.1 Merck & Co. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Rheumatology Drugs Introduction
12.10.4 Merck & Co. Revenue in Rheumatology Drugs Business (2014-2019)
12.10.5 Merck & Co. Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Rheumatology Drugs Key Market Segments
Table Key Players Rheumatology Drugs Covered
Table Global Rheumatology Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Rheumatology Drugs Market Size Market Share by Type 2014-2025
Figure Disease Modifying Anti-rheumatic Drugs Figures
Table Key Players of Disease Modifying Anti-rheumatic Drugs
Figure Nonsteroidal Anti-inflammatory Drugs Figures
Table Key Players of Nonsteroidal Anti-inflammatory Drugs
Figure Corticosteroids Figures
Table Key Players of Corticosteroids
Figure Uric Acid Drugs Figures
Table Key Players of Uric Acid Drugs
Figure Others Figures
Table Key Players of Others
Table Global Rheumatology Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacy Case Studies
Figure Retail Pharmacy Case Studies
Figure Online Pharmacy Case Studies
Figure Rheumatology Drugs Report Years Considered
Table Global Rheumatology Drugs Market Size 2014-2025 (Million US$)
Figure Global Rheumatology Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Rheumatology Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Rheumatology Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Rheumatology Drugs Market Share by Regions 2014-2019
Figure Global Rheumatology Drugs Market Share by Regions 2014-2019
Figure Global Rheumatology Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Rheumatology Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Rheumatology Drugs Market Share by Manufacturers (2014-2019)
Figure Global Rheumatology Drugs Market Share by Manufacturers in 2018
Table Global Rheumatology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Rheumatology Drugs Product/Solution/Service
Table Date of Enter into Rheumatology Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Rheumatology Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Rheumatology Drugs Market Size Share by Type (2014-2019)
Figure Global Rheumatology Drugs Market Size Market Share by Type (2014-2019)
Table Global Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Rheumatology Drugs Market Size Share by Application (2014-2019)
Figure Global Rheumatology Drugs Market Size Market Share by Application (2014-2019)
Figure Global Rheumatology Drugs Revenue Market Share by Application in 2018
Figure United States Rheumatology Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Rheumatology Drugs Market Share (2018-2019)
Table United States Rheumatology Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Rheumatology Drugs Market Share by Type (2014-2019)
Table United States Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Rheumatology Drugs Market Share by Application (2014-2019)
Figure Europe Rheumatology Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Rheumatology Drugs Market Share (2018-2019)
Table Europe Rheumatology Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Rheumatology Drugs Market Share by Type (2014-2019)
Table Europe Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Rheumatology Drugs Market Share by Application (2014-2019)
Figure China Rheumatology Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Rheumatology Drugs Market Share (2018-2019)
Table China Rheumatology Drugs Market Size by Type (2014-20189) (Million US$)
Table China Rheumatology Drugs Market Share by Type (2014-2019)
Table China Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Table China Rheumatology Drugs Market Share by Application (2014-2019)
Figure Japan Rheumatology Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Rheumatology Drugs Market Share (2018-2019)
Table Japan Rheumatology Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Rheumatology Drugs Market Share by Type (2014-2019)
Table Japan Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Rheumatology Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Rheumatology Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Rheumatology Drugs Market Share (2018-2019)
Table Southeast Asia Rheumatology Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Rheumatology Drugs Market Share by Type (2014-2019)
Table Southeast Asia Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Rheumatology Drugs Market Share by Application (2014-2019)
Figure India Rheumatology Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Rheumatology Drugs Market Share (2018-2019)
Table India Rheumatology Drugs Market Size by Type (2014-2019) (Million US$)
Table India Rheumatology Drugs Market Share by Type (2014-2019)
Table India Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Table India Rheumatology Drugs Market Share by Application (2014-2019)
Figure Central & South America Rheumatology Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Rheumatology Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Rheumatology Drugs Market Share (2018-2019)
Table Central & South America Rheumatology Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Rheumatology Drugs Market Share by Type (2014-2019)
Table Central & South America Rheumatology Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Rheumatology Drugs Market Share by Application (2014-2019)
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2014-2019) (Million US$)
Figure Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Rheumatology Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Genentech Company Details
Table Genentech Revenue in Rheumatology Drugs Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table Genentech Recent Development
Table Novartis Company Details
Table Novartis Revenue in Rheumatology Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table Novartis Recent Development
Table Janssen Biotech Company Details
Table Janssen Biotech Revenue in Rheumatology Drugs Business (2014-2019)(Million US$)
Figure Janssen Biotech Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table Janssen Biotech Recent Development
Table Amgen Company Details
Table Amgen Revenue in Rheumatology Drugs Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table Amgen Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Rheumatology Drugs Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table AbbVie Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Rheumatology Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table Pfizer Recent Development
Table Bristol-Myers Squibb Company Company Details
Table Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table Bristol-Myers Squibb Company Recent Development
Table Merck & Co. Company Details
Table Merck & Co. Revenue in Rheumatology Drugs Business (2014-2019)(Million US$)
Figure Merck & Co. Revenue Growth Rate in Rheumatology Drugs Business (2014-2019)
Table Merck & Co. Recent Development
Table Global Rheumatology Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Rheumatology Drugs Market Size Share by Regions (2019-2025)
Figure Global Rheumatology Drugs Market Size Share by Regions in 2025
Figure United States Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Rheumatology Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Rheumatology Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Rheumatology Drugs Market Size by Product (2019-2025)
Figure Global Rheumatology Drugs Market Size by Product in 2025
Table Global Rheumatology Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Rheumatology Drugs Market Size by Application (2019-2025)
Figure Global Rheumatology Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の骨髄異形成症候群（MDS）薬市場：市場規模・現状・予測

Global Myelodysplastic Syndrome (MDS) Drugs Market Size, Status and Forecast 2019-2025
QYR9N7611 2019年6月14日 96Pages
当資料は、骨髄異形成症候群（MDS）薬のグローバル市場について調査・分析したレポートで、種類別（低メチル化剤、免疫調節薬、抗貧血薬）、用途別（オリジナル、ジェネリック）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...

世界のうつ病薬市場：市場規模・現状・予測

Global Depression Drugs Market Size, Status and Forecast 2019-2025
QYR9N7085 2019年6月14日 98Pages
当資料は、うつ病薬のグローバル市場について調査・分析したレポートで、種類別（SSRI、SNRI、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・う...

世界の凍結乾燥注射薬市場：市場規模・現状・予測

Global Lyophilized Injectable Drugs Market Size, Status and Forecast 2019-2025
QYR9N7487 2019年6月14日 96Pages
当資料は、凍結乾燥注射薬のグローバル市場について調査・分析したレポートで、種類別（使い捨てバイアル、ポイントオブケア再構成、その他）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の非カタプレキシーナルコレプシー薬市場：市場規模・現状・予測

Global Non Cataplexy Narcolepsy Drugs Market Size, Status and Forecast 2019-2025
QYR9N7681 2019年6月14日 93Pages
当資料は、非カタプレキシーナルコレプシー薬のグローバル市場について調査・分析したレポートで、種類別（抗酸化薬、覚せい剤、その他）、用途別（子供（18歳未満）、成人（18〜50歳）、高齢者（50歳以上）、）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測...

世界のテネクテプラーゼ薬市場：市場規模・現状・予測

Global Tenecteplase Drugs Market Size, Status and Forecast 2019-2025
QYR9N8112 2019年6月14日 93Pages
当資料は、テネクテプラーゼ薬のグローバル市場について調査・分析したレポートで、種類別（静脈内投与量、カテーテル内点滴注入量）、用途別（病院、診療所、外来手術センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれてい...

世界の薄膜薬市場：市場規模・現状・予測

Global Thin Film Drugs Market Size, Status and Forecast 2019-2025
QYR9N8117 2019年6月14日 108Pages
当資料は、薄膜薬のグローバル市場について調査・分析したレポートで、種類別（経皮フィルム、口腔薄膜、その他）、用途別（病院、ドラッグストア、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の固形腫瘍薬市場：市場規模・現状・予測

Global Solid Tumors Drugs Market Size, Status and Forecast 2019-2025
QYR9N8070 2019年6月14日 108Pages
当資料は、固形腫瘍薬のグローバル市場について調査・分析したレポートで、種類別（小分子、生物製剤）、用途別（病院、診療所、学術研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・固形...

世界の副鼻腔炎の薬市場：市場規模・現状・予測

Global Sinusitis Drugs Market Size, Status and Forecast 2019-2025
QYR9N8045 2019年6月14日 97Pages
当資料は、副鼻腔炎の薬のグローバル市場について調査・分析したレポートで、種類別（鎮痛薬、抗ヒスタミン薬、コルチコステロイド、抗生物質、スルホンアミド）、用途別（急性副鼻腔炎、慢性副鼻腔炎）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界の鼻出血薬市場：市場規模・現状・予測

Global Epistaxis Drugs Market Size, Status and Forecast 2019-2025
QYR9N7169 2019年6月14日 99Pages
当資料は、鼻出血薬のグローバル市場について調査・分析したレポートで、種類別（血管収縮薬、麻酔薬、抗生物質軟膏、焼灼剤、その他）、用途別（病院、診療所、小売薬局、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。...

世界のチロシンヒドロキシラーゼ欠乏薬市場：市場規模・現状・予測

Global Tyrosine Hydroxylase Deficiency Drugs Market Size, Status and Forecast 2019-2025
QYR9N8151 2019年6月14日 99Pages
当資料は、チロシンヒドロキシラーゼ欠乏薬のグローバル市場について調査・分析したレポートで、種類別（トリヘキシフェニジル、アマンタジン、その他）、用途別（病院、診療所、診断センター、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報な...

世界の非ステロイド系抗炎症薬（NSAID）市場：市場規模・現状・予測 Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and ki…
世界の炎症性皮膚疾患薬市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key …
世界のメニエール病の薬市場：市場規模・現状・予測 Meniere’s disease is a disorder of middle ear that causes vertigo, ringing sound in the ear and hearing problems. In most of the cases this disease only affects one ear. Meniere’s disease can affect anyone but the prevalence is on a higher side in people aged from 20-50. This is a chronic disease bu…
世界のウィルソン病薬市場：市場規模・現状・予測 In 2018, the global Wilson's Disease Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Wilson's Disease Drugs status, future forecast, growth opportunity, key market and key playe…
世界の非アルコール性脂肪性肝炎（NASH）薬市場：市場規模・現状・予測 Nonalcoholic steatohepatitis is a form of liver disease that develops in patients who are not alcoholic. The major feature in NASH is fat deposition in the liver, along with inflammation and damage to the liver. Most patients with NASH are not aware that they are suffering from a liver problem. Howe…